Driving change to defeat serious chronic diseases, built upon our heritage in diabetes.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 63,400 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Pharmaceuticals, Insulin, obesity, Rare Diseases, and Diabetes
Novo Nordisk | driving change to defeat serious chronic diseases
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
LA FNIM healthtech, Business Consulting and Services | Other 3 May 2024 | | ||
aMoon Fund Venture Capital and Private Equity Principals | Other 31 Mar 2024 | | ||
Bloom Partners Consulting, martech, Business Consulting and Services | Other 29 Apr 2024 | | ||
Orakl Oncology biotech, deeptech, Biotechnology Research | Other 30 Apr 2024 | | ||
Cellarity biotech, deeptech | Other 29 Apr 2024 | | ||
Medrise Studio biotech, deeptech, healthtech, Pharmaceutical Manufacturing | Other 25 Apr 2024 | | ||
Climate & Capital Media fintech, greentech, cleantech, Online Audio and Video Media | Other 23 Apr 2024 | | ||
Executive Forum España martech, Public Relations and Communications Services | Other 21 Apr 2024 | | ||
Habitual healthtech, Hospitals and Health Care | Other 21 Apr 2024 | | ||
SRAE NUTRITION healthtech, Wellness and Fitness Services | Other 13 Apr 2024 | |